Delivery Order SPE2DB22D2206-SPE2DB25FKD28
- Not listed
- The Defense Logistics Agency awarded a $14,837.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,338.74 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL pharmaceutical products on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Orencia ClickJect is a biologic medication used in the treatment of rheumatoid arthritis and other...
- The Defense Logistics Agency (DLA) awarded a $26,329.73 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitive award carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL pharmaceutical supplies, valued at $37,213.29. This firm fixed-price delivery order, issued on September 25, 2025, with a completion date of September 26, 2025, represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Orencia ClickJect is a biologic disease-modifying...
- The Defense Logistics Agency awarded a $27,538.31 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml on April 21, 2025, with completion scheduled for April 22, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger prime vendor agreement with DLA Troop Support Medical. Orencia (abatacept) is a biologic medication commonly used to treat rheumatoid arthritis and other autoimmune conditions, with the...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $38,612.57 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL on July 31, 2025, with completion scheduled for August 1, 2025. This competitive award utilizes firm fixed-price pricing and represents a child contract under the contractor's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $20,206.26 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a pharmaceutical product used in treating autoimmune conditions. This competitive award, issued on September 17, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. The contract involves performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,144.19 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. Orencia (abatacept) is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune...
- The Defense Logistics Agency awarded a delivery order valued at $3,594.04 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract, which involved no set-aside designation, represents a competitively awarded delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at...
- The Defense Logistics Agency awarded a $19,295.10 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on September 3, 2025, with an ultimate completion date of September 4, 2025, indicating expedited fulfillment requirements. The product will be delivered to Conshohocken,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKD28Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,865.87 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract with performance in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Orencia Clickject is a biologic medication used for treating rheumatoid arthritis and other autoimmune conditions. This delivery order exemplifies AmerisourceBergen's critical role as a major pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains through the DLA's Medical Supply Chain, enabling the distribution of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support defense health operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 9/26/25 |